Stockscreener 앱 받기
3.62
1.97%
0.07
Adc Therapeutics Sa 주식(ADCT)의 최신 뉴스
Short Interest in ADC Therapeutics SA (NYSE:ADCT) Drops By 47.2% - MarketBeat
ADCT: Zynlonta's pivotal trials aim to transform its market reach and drive major growth from 2027 - TradingView — Track All Markets
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year? - sharewise.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SAADCT - Chartmill
Bull Bear: Why ADC Therapeutics SA stock could benefit from AI revolution2025 Risk Factors & Weekly High Momentum Picks - Bộ Nội Vụ
ADC Therapeutics SA (NYSE:ADCT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
ADC Therapeutics posts preliminary 2025 revenue of about $73M - MSN
ADC Therapeutics outlines ZYNLONTA-focused growth and financing strategy - TipRanks
How geopolitical tensions affect ADC Therapeutics SA stock2025 Sector Review & Technical Buy Zone Confirmations - Улправда
Can ADC Therapeutics SA Common Shares stock sustain margin levelsCEO Change & Low Drawdown Trading Techniques - Улправда
Is ADC Therapeutics SA Common Shares stock testing key supportQuarterly Market Review & Free High Accuracy Swing Entry Alerts - Улправда
ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Sahm
ADC Therapeutics Announces Preliminary 2025 Financial Results and Outlook - TipRanks
Can ADC Therapeutics SA stock rebound after recent weakness2025 Winners & Losers & Free Reliable Trade Execution Plans - Улправда
ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates - Nasdaq
ADC Therapeutics SA Common Shares (NY: ADCT - markets.financialcontent.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC ... - Bluefield Daily Telegraph
Will ADC Therapeutics SA stock outperform international peers2026 world cup usa national team round of 32 top scorers high defensive line tactical prediction guide - ulpravda.ru
ADCT stock touches 52-week low at $1.42 amid market challenges - MSN
ADC Therapeutics Announces New Employee Inducement Grant - 富途牛牛
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Graphic Packaging Holding Company - GlobeNewswire Inc.
ADC Therapeutics (ADCT) Upgraded to Buy: Here's Why - Yahoo Finance
Is ADC Therapeutics SA a good long term investmentOptions Trading Strategies & Free Take Advantage Of Momentum - earlytimes.in
Corient Private Wealth LLC Makes New Investment in ADC Therapeutics SA $ADCT - MarketBeat
Risk Report: Will ADC Therapeutics SA stock beat EPS estimatesQuarterly Profit Report & Fast Gaining Stock Reports - Улправда
Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines - marketscreener.com
Is ADC Therapeutics SA stock a contrarian buyJuly 2025 Macro Moves & Fast Gaining Stock Strategy Reports - Улправда
ADC Therapeutics SA (NYSE:ADCT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Will ADC Therapeutics SA stock beat EPS estimatesMarket Activity Report & Safe Entry Zone Identification - Улправда
Wall Street Recap: Is ADC Therapeutics SA Common Shares stock undervalued historically2025 EndofYear Setup & Weekly High Return Forecasts - Улправда
How buybacks impact ADC Therapeutics SA stock value2025 Investor Takeaways & Entry and Exit Point Strategies - Улправда
Is ADC Therapeutics SA Common Shares stock undervalued historically2025 Big Picture & Weekly Momentum Stock Picks - Улправда
RBC Capital Bullish on ADC Therapeutics S.A. (ADCT) on Lymphoma Treatment Development - Yahoo Finance
Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year? - sharewise.com
ADC Therapeutics (NYSE:ADCT) Sees Large Volume IncreaseStill a Buy? - MarketBeat
ADC Therapeutics SA (ADCT) is a Great Momentum Stock: Should You Buy? - sharewise.com
ADC Therapeutics SA (NYSE:ADCT) Q1 2025 Earnings Call Transcript - MSN
4.73%
0.92%
자본화:
|
볼륨(24시간):